Uploaded on Jul 4, 2022
Cardiovascular ultrasound or imaging allows healthcare professionals to monitor changes in heart structure to detect the presence of any abnormality or medical conditions such as diabetes, hypertension or other cardiovascular diseases.
Cardiovascular Ultrasound Treatment Market Share, Size, Forecast 2022
Cardiovascular ultrasound or imaging allows healthcare professionals to monitor changes in heart
structure to detect the presence of any abnormality or medical conditions such as diabetes,
hypertension or other cardiovascular diseases. The global cardiovascular ultrasound market is
estimated to strike a CAGR of 6.3% over the forecast period of 2017-2023, predicts Market Research
Future (MRFR). After extensively analysing the market MRFR expects the global cardiovascular
ultrasound market to attain a valuation of USD 1.72 Bn by the end of 2023 which stood at USD 1.45
Bn in 2016.
Cardiovascular diseases continue to be among the top reasons for hospitalization and deaths across
the globe. Surging prevalence of heart diseases requires early detection of such diseases to allow
physicians to provide timely treatment. The global Cardiovascular Ultrasound Market Size is
expanding against the backdrop of an alarming increase in the incidence rate of heart diseases.
Cardiovascular ultrasound techniques such as echocardiography, angiography, nuclear cardiac
imaging, computed tomography, cardiac positron emission tomography (cardiac PET) and cardiac
magnetic resonance imaging (cardiac MRI) are extensively used for the determination of any
abnormalities. Not only are these methods effective but also non-invasive which has led to increased
adoption of these methods.
Cardiovascular ultrasound or imaging devices are subject to strict monitoring by the FDA and other
regulatory bodies which can constrain the market growth over the forecast period. Moreover,
cardiovascular ultrasound tools are expensive and diagnostic tests result in burgeoning healthcare
costs which can impede the growth of the market in price-sensitive regions.
Segmentation
The global cardiovascular ultrasound market has been segmented based on type of imaging,
imaging technology, and end user.
By type of imaging, the global cardiovascular ultrasound market has been segmented into
transthoracic, trans esophageal, echocardiograms, stress, and abdominal vasculature ultrasound
imaging.
By imaging technology, the global cardiovascular ultrasound market has been segmented into 2D,
3D and Color Doppler.
By end user, the global cardiovascular ultrasound market has been segmented into hospitals and
clinics, diagnostic centers and others.
Competitive Landscape
Philips Healthcare (The Netherlands), Toshiba Medical Systems Corporation (Japan), Siemens
Healthcare (Germany), Hitachi Medical Corporation (Japan), and GE Healthcare (U.S.) are the key
players in the global cardiovascular ultrasound market.
Regional Analysis
By region, the global cardiovascular ultrasound market has been segmented into the Americas, Asia
Pacific (APAC), Europe, and the Middle East & Africa (MEA).
North America is the largest market for cardiovascular ultrasound market. High prevalence of
cardiovascular diseases and robust healthcare infrastructure supports the growth of the market in
the region. Moreover, high healthcare expenditure, favorable reimbursement policies, and the
presence of various medical device manufacturers in the region also acts as a plus for the growth of
the market.
APAC is expected to be the fastest growing market for cardiovascular ultrasound market. Surging
prevalence of cardiovascular diseases and the presence of a massive patient pool are factors driving
growth within the APAC market. In addition, diabetes is also a common prevalent condition in the
region which exposes patients at greater risk of acquiring heart diseases. High expenditure on
healthcare infrastructure and government support for the same us fostering the growth of the
market in the region.
Industry Updates
July 2018- The U.S. FDA cleared a new device for transesophageal echocardiogram, TEECAD System.
The device has been developed by Visura Technologies, a medical device company which allows
viewing the upper airway and esophagus. The device is equipped with a single-use disposable
camera which can capture high-resolution ultrasound images of the heart valves and atria.
About US:
Market Research Future (MRFR) enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR),
Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments